Drug: VYVANSE Injury: No adverse event Quarter: 2016Q3
Total Records: 32 Number of Pages: 2
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 124072902 | VYVANSE | No adverse event | SHIRE | 0.00 | F | 0 | 20160709 | US |
| 124976182 | VYVANSE | No adverse event | SHIRE | 0.00 | F | 62 KG | 20160713 | US |
| 125455312 | VYVANSE | No adverse event | SHIRE | 20.00 YR | F | 0 | 20160801 | US |
| 125519251 | VYVANSE | No adverse event | SHIRE | 4.00 YR | M | 16 KG | 20160713 | US |
| 125531071 | VYVANSE | No adverse event | SHIRE | 0.00 | F | 0 | 20160713 | US |
| 126142091 | VYVANSE | No adverse event | SHIRE | 18.00 YR | F | 0 | 20160802 | US |
| 126484631 | VYVANSE | No adverse event | SHIRE | 0.00 | M | 0 | 20160812 | US |
| 126492071 | VYVANSE | No adverse event | SHIRE | 13.00 YR | M | 0 | 20160812 | US |
| 126502001 | VYVANSE | No adverse event | SHIRE | 0.00 | F | 0 | 20160813 | US |
| 126920991 | VYVANSE | No adverse event | SHIRE | 0.00 | F | 0 | 20160827 | US |
| 126923781 | VYVANSE | No adverse event | SHIRE | 5.56 YR | M | 25 KG | 20160828 | US |
| 126960661 | VYVANSE | No adverse event | SHIRE | 15.00 YR | M | 76 KG | 20160829 | US |
| 126961221 | VYVANSE | No adverse event | SHIRE | 0.00 | 0 | 20160829 | US | |
| 126978152 | VYVANSE | No adverse event | SHIRE | 5.51 YR | M | 20 KG | 20160914 | US |
| 126986441 | VYVANSE | No adverse event | SHIRE | 0.00 | F | 0 | 20160830 | US |
| 126991461 | VYVANSE | No adverse event | SHIRE | 12.00 YR | M | 0 | 20160830 | US |
| 127275861 | VYVANSE | No adverse event | SHIRE | 0.00 | F | 0 | 20160909 | US |
| 127294212 | VYVANSE | No adverse event | SHIRE | 0.00 | M | 0 | 20160930 | US |
| 127301921 | VYVANSE | No adverse event | SHIRE | 0.00 | M | 0 | 20160909 | US |
| 127302411 | VYVANSE | No adverse event | SHIRE | 0.00 | F | 0 | 20160909 | US |
Total Records: 32 Number of Pages: 2